How Long Do COVID-19 Hives Last and What to Do

Most COVID-19 hives clear up within about a week, with treatment typically bringing relief in anywhere from less than a day to around two weeks. That is the picture for the large majority of people who develop this itchy, raised rash during or shortly after a SARS-CoV-2 infection. A small fraction, however, tip into chronic hives that can persist for a year or longer, sometimes becoming part of the broader long COVID picture. Understanding the difference between a short flare and a lingering problem, and knowing what actually helps, matters for deciding when you can ride it out and when you need a doctor’s involvement.

How Long Acute COVID Hives Typically Last

A systematic review of urticaria in COVID-19 patients found that skin lesions resolved in a range spanning less than 24 hours up to about two weeks when patients were treated with antihistamines, corticosteroids, or both.¹ A study that specifically compared acute and chronic cases put the average duration of acute COVID hives at roughly seven days.² So if you develop hives during a COVID infection and start an antihistamine, there is a reasonable chance the rash will be noticeably better within a few days and gone within one to two weeks.

The word “acute” here just means the hives come and go relatively quickly, as opposed to chronic hives that keep recurring for six weeks or more. Most people who break out in hives during COVID fall into the acute camp. Individual wheals can appear, fade, and reappear in different spots over the course of a single day, which can feel alarming but is normal for urticaria of any cause.

When Hives Show Up Relative to Other COVID Symptoms

You might assume hives are a late symptom, showing up well after the cough and fever. The reality is more mixed. A review of over 200 patients found that in more than half of those whose timing could be pinpointed, the rash appeared before or at the same time as the classic respiratory and systemic symptoms of COVID-19.³ Case reports have documented urticarial rashes as the very first sign of infection, turning up before fever, cough, or loss of taste.⁴

In the acute cases that went on to be studied more carefully, hives tended to start an average of about four to five days after the COVID infection began.² That said, the spread is wide, and your rash could appear on day one or not until a week into the illness. If you develop unexplained hives during a time when respiratory viruses are circulating, it is worth considering COVID as a possible trigger even if you do not yet have a cough.

How Common Are Hives During COVID

Urticaria is one of the more frequently reported skin findings in COVID-19, though exact numbers vary depending on how carefully researchers went looking. Estimates of prevalence among COVID patients have ranged from roughly 3% to about 15%.⁵ That wide range reflects differences in study design: dermatologists systematically examining every hospitalized patient will catch more rashes than surveys relying on patients to self-report.

Hives from COVID have been reported across an enormous age range, from infants as young as two months to adults in their eighties. Women seem to be affected more often, accounting for about two-thirds of cases in one large review.³ That skew mirrors chronic urticaria in general, which is more common in women regardless of the trigger. The rash most often shows up as widespread wheals across the trunk, though it can appear almost anywhere on the body.

Why COVID Triggers Hives in the First Place

Hives happen when mast cells in the skin release histamine and other inflammatory chemicals, causing small blood vessels to leak fluid into surrounding tissue. That leaking produces the characteristic raised, itchy welts. The question is why SARS-CoV-2 sets off mast cells in some people.

The leading explanation centers on the storm of signaling molecules the immune system releases while fighting the virus. Cytokines including interferons, TNF-alpha, and various chemokines ramp up during infection, and these can directly trigger mast cells and related immune cells called basophils to dump their contents, a process called degranulation.⁶ It is not that the virus is infecting your skin cells directly. Instead, your immune response to the virus is spilling over and irritating mast cells that happen to be stationed in the skin.

This mechanism helps explain why hives sometimes precede the more recognizable symptoms. Your immune system can begin mounting an inflammatory response before you feel sick enough to notice a fever or sore throat, and the mast cells in your skin may react to those early immune signals before the respiratory symptoms kick in.

What to Do When COVID Hives Appear

For most people, the first-line treatment is straightforward: a second-generation antihistamine like cetirizine, loratadine, or fexofenadine. These are available over the counter and block the histamine that mast cells are releasing. The systematic review covering treatment outcomes in COVID urticaria patients found that antihistamines alone, or antihistamines combined with short courses of corticosteroids, resolved the rash in the majority of cases.¹

A few practical points are worth keeping in mind:

Dosing: Standard once-daily doses are a reasonable starting point, but dermatologists sometimes recommend up to two or even four times the standard dose of a second-generation antihistamine for stubborn hives. This is an off-label approach, so check with your doctor before escalating on your own.
Older antihistamines: First-generation antihistamines like diphenhydramine can help with itching and may help you sleep, but they cause more drowsiness and dry mouth. They are a reasonable add-on at bedtime, not an ideal daytime choice.
Cool compresses: Applying a cool, damp cloth to itchy areas can temporarily reduce swelling and calm the itch without any medication interaction concerns.
Avoid triggers: Heat, tight clothing, hot showers, alcohol, and stress can all worsen hives regardless of the underlying cause. While you are dealing with the rash, keeping your skin cool and loosely covered helps.

Short courses of oral corticosteroids like prednisone are sometimes prescribed when antihistamines alone are not enough. These are effective but come with side effects if used for more than a few days, and there has been some caution about systemic steroids during active COVID infections because of their immune-suppressing effects. Your doctor will weigh the severity of the rash against any risk, especially if you are still in the acute phase of the infection.

When Hives Turn Chronic After COVID

The scenario that worries people most is hives that do not stop. Chronic spontaneous urticaria, defined as recurring hives lasting six weeks or more without a clear external trigger, can develop after a COVID infection. One study comparing the two groups found that chronic cases had a mean duration of about 13 months, versus roughly seven days for acute cases.² The chronic group also had a longer gap between the COVID infection and the start of hives, averaging about three weeks rather than four to five days.

Chronic spontaneous urticaria has been recognized as one of the conditions that can emerge as part of long COVID.⁷ And research into long COVID more broadly has found that mast cell activation symptoms in long COVID patients closely mirror those seen in mast cell activation syndrome, a condition where mast cells are chronically overreactive.⁸ This overlap suggests that in some people, COVID may leave the mast cell system stuck in a heightened state long after the virus itself is gone.

If your hives have been coming and going for more than six weeks after a COVID infection, that is a strong signal to see a dermatologist or allergist rather than continuing to self-treat. The treatment approach for chronic post-COVID hives is essentially the same as for chronic spontaneous urticaria from any cause: daily antihistamines as a baseline, with biologic medications like omalizumab available as a second-line option for cases that do not respond.⁹ Omalizumab works by blocking the antibody IgE, which reduces mast cell activation through a different pathway than antihistamines.

If You Already Had Chronic Hives Before Catching COVID

People who were already living with chronic spontaneous urticaria before getting infected face a somewhat different concern. A retrospective study found that about 44% of chronic urticaria patients experienced a worsening of their hives during or after COVID-19, with flares more common in those who had moderate-to-severe COVID infections.¹⁰ Inflammatory markers like C-reactive protein tracked with worsening hive severity, reinforcing the idea that the general inflammation from COVID fans the flames of a pre-existing mast cell problem.

The reassuring finding from the same research is that having chronic urticaria did not seem to make COVID infections worse. The risk runs in one direction: COVID aggravates existing hives, but the hives do not make you more vulnerable to severe COVID. If you are on a maintenance regimen for chronic urticaria and you catch COVID, it may be worth contacting your dermatologist early rather than waiting for a flare to become unmanageable. A temporary dose adjustment of your antihistamines or a short course of additional medication can sometimes head off a major exacerbation.

Telling COVID Hives Apart From a Drug Reaction

This is where things get tricky in practice. If you develop hives while sick with COVID, the rash could be caused by the virus itself, by a medication you started taking for COVID symptoms, or by both at once. Many COVID patients take antipyretics, antibiotics, antivirals, and other drugs, any of which can trigger hives as a side effect. A review of cutaneous findings in COVID noted the importance of distinguishing between virus-driven and drug-induced skin lesions, since the treatment and prognosis differ.¹¹

There is no single test that definitively separates the two. Timing can help: hives that appeared before you took any medications are more likely viral, while hives that started a day or two after beginning a new drug deserve suspicion. If you stop the suspected medication and the hives clear within 24 to 48 hours, the drug was likely the culprit. If they persist despite stopping the drug, the virus or its aftermath is a more likely explanation. When in doubt, your doctor may try switching you to an alternative medication to see if the rash improves.

How Different Variants Affected Skin Symptoms

The likelihood and duration of skin symptoms from COVID have not stayed constant across waves of the pandemic. A large study using data from nearly 350,000 users of a symptom-tracking app in the UK found that skin manifestations were reported by about 18% of infected users during the Delta wave, compared to about 11% during Omicron.¹² Skin symptoms also lasted longer on average during the Delta wave than during Omicron.

This trend fits with the broader observation that newer variants have tended to cause less systemic inflammation. Less inflammatory signaling means fewer stray cytokines nudging mast cells toward degranulation. For someone catching COVID today, the probability of developing hives is likely lower than it was in 2020 or 2021, though it certainly has not dropped to zero. And if future variants shift the immune response in different ways, the skin picture could change again.

Hives After COVID Vaccination

Hives can also appear after COVID vaccination rather than after the infection itself, and the profile looks somewhat different. A study tracking post-vaccination chronic urticaria found that hives typically started about 10 days after vaccination and disproportionately affected middle-aged women. By 2023, the condition was still active in over half of the tracked cases, and many of those patients had developed inducible forms of urticaria, particularly dermographism, where the skin welts up in response to pressure or scratching.¹³

A noteworthy finding from the same study was that patients who developed chronic urticaria after vaccination were able to tolerate an additional dose of mRNA vaccine without their hives flaring or recurring. That matters because people understandably worry about getting another shot if the last one seemed to trigger months of hives. While one study does not settle the question for everyone, it offers some reassurance that revaccination does not necessarily restart the problem.

COVID Hives in Children

Children can develop urticarial rashes during COVID, and in at least one documented case, hives were the very first and most prominent sign of the infection in a pediatric patient.⁵ The skin manifestations of COVID in children span a wide range of appearances, from flat red spots to blisters to hive-like welts, but the prognosis for isolated skin involvement is generally self-limiting.¹⁴

The main challenge for parents is the sheer variety of rashes that children develop during viral illnesses of all kinds. A child with new-onset hives during cold-and-flu season could have COVID, another virus, or a reaction to medication. The management is essentially the same regardless: an age-appropriate antihistamine, avoidance of irritants, and monitoring. If the child develops difficulty breathing, facial swelling, or any sign of anaphylaxis alongside the hives, that warrants emergency care immediately, as it would for hives from any cause.

Do COVID Hives Signal Anything About Disease Severity

One practical question people have is whether developing hives means your COVID case is going to be mild or severe. The evidence here is mixed but leans cautiously optimistic. A review of cutaneous signs across COVID patients suggested that certain skin manifestations correlate with a milder disease course, while others, like the purple-blue lesions associated with vascular damage, tend to signal more serious illness.¹⁵ Urticaria-type rashes generally fall on the milder end of that spectrum, though they are not a guarantee of an easy course.

The more relevant concern may be the reverse relationship. Hives that are unusually severe, widespread, or resistant to antihistamines could reflect a higher level of systemic inflammation, which in turn might correlate with a more intense immune response to the virus. If your hives are not responding to over-the-counter antihistamines after two or three days, that is a good reason to contact your doctor, both for better rash management and as a general check-in on how the infection itself is progressing.

When to Seek Medical Attention

Mild hives during a COVID infection are manageable at home for most people. But certain situations call for professional evaluation sooner rather than later:

Breathing trouble or throat tightness: Hives accompanied by swelling of the lips, tongue, or throat, or by difficulty breathing, may indicate anaphylaxis. This is a medical emergency regardless of the cause.
No improvement after a week: If standard-dose antihistamines have not made a dent after seven to ten days, you may need a higher dose, a different medication, or a reassessment of whether the rash is actually hives versus another skin condition.
Hives persisting past six weeks: At this point the condition meets the clinical definition of chronic urticaria and warrants evaluation by a specialist. Blood work and sometimes skin testing can help guide longer-term management.
New hives weeks after recovery: If your COVID infection resolved and hives show up for the first time three or more weeks later, the pattern more closely matches the chronic subtype seen in post-COVID cases and is worth flagging early.

The vast majority of COVID-related hives are an uncomfortable nuisance rather than a dangerous complication. They itch, they look alarming, and they interrupt sleep, but they respond to the same treatments that work for hives triggered by other viruses, allergens, or stress. Where COVID adds a wrinkle is in the small but real possibility that the rash becomes a chronic condition tied to ongoing immune dysregulation. Catching that transition early and getting appropriate specialist care can make the difference between months of frustration and a faster path to control.

1
PubMed Central. Management of urticaria in COVID-19 patients: A systematic review
2
Advances in Skin & Wound Care. Clinical Features and Outcomes of Acute versus Chronic Urticaria Triggered by COVID-19 Infection
3
PubMed. Urticaria and COVID-19: A review
4
BMJ Case Reports. Severe urticarial rash as the initial symptom of COVID-19 infection
5
PubMed Central. Acute urticaria as the initial presentation of COVID-19 in a pediatric patient
6
PubMed. What the physicians should know about mast cells, dendritic cells, urticaria, and omalizumab during COVID-19 or asymptomatic infections due to SARS-CoV-2?
7
The Journal of Allergy and Clinical Immunology: In Practice. The Long Road of Long COVID: Specific Considerations for the Allergist/Immunologist
8
PubMed Central. Mast cell activation symptoms are prevalent in Long-COVID
9
PubMed Central. COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports
10
PubMed Central. COVID-19 Disease Leading to Chronic Spontaneous Urticaria Exacerbation: A Romanian Retrospective Study
11
PubMed Central. SARS-CoV-2, COVID-19, skin and immunology – What do we know so far?
12
British Journal of Dermatology. Cutaneous manifestations of SARS‐CoV‐2 infection during the Delta and Omicron waves in 348 691 UK users of the UK ZOE COVID Study app
13
Communications Medicine. Features of chronic urticaria after COVID-19 mRNA vaccine over time
14
JEADV Clinical Practice. Rare and common manifestations of COVID-19 in children
15
PubMed Central. Cutaneous signs in COVID-19 patients: A review